Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-02-23

Clinical Trial Update: Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs [NA]

View source ↗

Summary

Clinical trial update on high-velocity nasal insufflation (HVNI) with new cannula designs for relief of dyspnea; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vapotherm, Inc. | Conditions: Dyspnea, Hypercapnia | NA | Status: COMPLETED | Results posted: 2024-02-23